Literature DB >> 28463437

Primary malignant pericardial sarcomatoid mesothelioma: An autopsy report.

Hiroko Muta1, Yasuo Sugita1, Koichi Ohshima1, Hitoshi Otsubo2.   

Abstract

Primary malignant pericardial sarcomatoid mesothelioma (PMPSM) is an extremely rare tumor with poor prognosis. We present an autopsy case in an 80-year-old man admitted for heart failure after one month of treatment at an outpatient clinic. He died three months after symptom onset. A complete autopsy revealed localization of the tumor to the pericardium without other lesions. Histologically, mainly spindle-shaped atypical cells with hyperchromatic nuclei and nucleoli were observed. Immunohistochemical markers for mesothelioma were positive for calretinin, cytokeratin AE1/AE3, and cytokeratin CAM5.2. Thus, we diagnosed primary sarcomatoid malignant mesothelioma of the pericardium. To our knowledge, only four PMPSM cases have been reported in the English literature in the past 30 years. Although PMPSM is rare, clinicians and pathologists should recognize it as a possible diagnosis of pericardial tumors. It is necessary to accumulate clinical and pathological diagnostic findings to establish early detection methods for this extremely rare disease.
© 2017 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  immunostaining; malignant mesothelioma; pericardium; sarcomatoid type

Mesh:

Substances:

Year:  2017        PMID: 28463437     DOI: 10.1111/pin.12535

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Intermittent Superior Vena Cava Syndrome Secondary to Malignant Pericardial Mesothelioma.

Authors:  Sarah A Alwusaibie; Jaffar S Alsayigh; Dunya Alfaraj; Abdullatif M Alomair; Sarah A Alsaeed
Journal:  Cureus       Date:  2020-12-16

Review 2.  Localized biphasic malignant mesothelioma presenting as a giant pelvic wall mass: a rare case report and literature review.

Authors:  Yunsong Liu; Jingjun Wu; Ying Zhao; Pengxin Zhang; Zhengyu Hua; Wan Dong; Tao Lin; Ailian Liu
Journal:  BMC Med Imaging       Date:  2020-05-06       Impact factor: 1.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.